Intermittent Cyclic Therapy with Etidronate Prevents Corticosteroid-induced Bone Loss: Two Years of Follow-up
Rolf J. Sebaldt(Murdoch Children's Research Institute), C. H. Goldsmith, Marjorie Steele, Marilyn Gordon(University of Calgary), A. Cividano(St. Joseph's Hospital), Gary L. Craig(St. Joseph's Hospital), Jonathan D. Adachi(St. Peter's Hospital), F Bianchi, Ann Cranney(St. Joseph's Hospital), W. Bensen(St. Joseph Hospital), Elżbieta Kamińska(St. Joseph's Hospital)
Cited by 23
Related Papers
Intermittent Etidronate Therapy to Prevent Corticosteroid-Induced Osteoporosis
|New England Journal of Medicine|1997|694
Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup.
|PubMed|1996|209
Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health
|American Journal of Clinical Nutrition|2008|208
The impact of incident fractures on health-related quality of life: 5 years of data from the Canadian Multicentre Osteoporosis Study
|Osteoporosis International|2008|195